UAE Cuts Oil Supplies To Asia As COVID Shutdowns Weaken Economy
The United Arab Emirates (UAE) will reduce its crude oil exports to some term contract clients in its core market Asia by 5% in December.
Gilead-Arcus Biosciences Partnered Lung Cancer Therapy Shows Continuous Positive Efficacy Measures
Gilead Sciences Inc (NASDAQ:GILD) and Arcus Biosciences (NASDAQ:RCUS) announced an update from the fourth interim analysis of Phase 2 ARC-7 study in patients…
Biogen’s Potential Early Alzheimer’s Treatment Sees Second Death Linked To It, Shares Fall
A 65-year-old woman with early Alzheimer's disease receiving Biogen Inc's (NASDAQ: BIIB) antibody lecanemab treatment to slow the cognitive decline recently died from a massive brain hemorrhage that some researchers link to the drug.
AstraZeneca Bets On UK Listed Firm For Lung Diseases
Drug Discovery company C4X Discovery Holdings plc has signed an exclusive worldwide licensing agreement with AstraZeneca plc (NASDAQ:AZN) worth up to $402…
UK Study Finds Pfizer/Bristol Myers Clotting Drug Does Not Help COVID-19 Patients
According to a U.K. trial, Eliquis (apixaban), widely prescribed for COVID-19, did not help patients recovering from moderate and severe COVID.
The drug used after discharge from the hospital does not lessen the chances for COVID-19 patients of readmission or improve survival.
Barron’s Top Weekend Stock Picks: Alibaba, Amazon, Apple And The Quantum Computing Revolution
Benzinga reviews this weekend's top stories covered by Barron's, here are the articles investors need to read.
Bulls And Bears Of The Week: Tesla, GameStop, And Cathie Wood Still Says Bitcoin Will Reach $1M
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.
European Official Says COVID-19 Booster Uptake Disappointing In The Region
Marco Cavaleri, the European Medicines Agency's (EMA) head of health threats and vaccines strategy, said the recent uptake of COVID-19 vaccine booster doses in the region has been "rather disappointing."
The European average rate of receiving booster doses was only 29% in the groups considered to be at the highest risk.
Ken Griffin’s Hedge Fund Increased Its Stake By Over 150% In These 2 Dividend-Paying Energy Stocks
Kenneth Griffin, who began trading stocks in his Harvard dorm in 1987, is the founder, CEO and co-CIO of Citadel Advisors.
Baxter Recalls WatchCare Incontinence Management System, Due To Interference Risk
The FDA classified Baxter International Inc’s (NYSE:BAX) recall of hospital bed systems as the most serious type of concern that it…